Adaptive Biotechnologies Corp (NAS:ADPT)
$ 3.32 -0.14 (-4.06%) Market Cap: 489.26 Mil Enterprise Value: 296.04 Mil PE Ratio: 0 PB Ratio: 1.77 GF Score: 72/100

Adaptive Biotechnologies Corp at Bank of America Merrill Lynch Healthcare Conference (Virtual) Transcript

May 13, 2020 / 07:00PM GMT
Release Date Price: $35.57 (-6.54%)
Derik De Bruin
BofA Merrill Lynch, Research Division - MD of Equity Research

Good afternoon, everyone. Welcome to the Bank of America 2020 Virtual Vegas Health Care Conference. I'm Derik de Bruin, the life sciences and diagnostic tools analyst -- senior analyst. With me today is my associate, Ivy Ma, who also covers diagnostics on the team. And we're very happy to talk with our next company, Adaptive Biotechnologies. With us is Chad Robins, Chief Executive Officer of Adaptive. Welcome, Chad.

Chad M. Robins
Adaptive Biotechnologies Corporation - Co-Founder, CEO & Chairman

Thanks, Derik and Ivy, for having me. Appreciate it.

Questions & Answers

Derik De Bruin
BofA Merrill Lynch, Research Division - MD of Equity Research

Our pleasure. So the -- we're in a sort of a different world than we were a few weeks ago. I think when we last spoke, we were -- you were going to come down to do a lunch for us in Seattle for -- our bus trip got canceled, and I think we didn't really appreciate it. But I mean a lot

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot